Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
Medley, Inc. ( (JP:4480) ) just unveiled an announcement.
Medley, Inc. has announced a restructuring of its board of directors and management team, slated for formal approval in March 2025. The reorganization includes the nomination of seven directors, with a mix of internal leadership and new external expertise, aimed at strengthening the company’s governance and strategic direction.
More about Medley, Inc.
Medley, Inc. is a company listed on the Tokyo Stock Exchange’s Prime Market, specializing in healthcare and technology services. The company focuses on providing innovative solutions to enhance medical practices and patient care.
YTD Price Performance: 2.61%
Average Trading Volume: 70
Technical Sentiment Consensus Rating: Buy
Current Market Cap: €796M
For an in-depth examination of 4480 stock, go to TipRanks’ Stock Analysis page.